Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence

European Psychiatry : the Journal of the Association of European Psychiatrists
Mariachiara BuonocoreR Cavallaro

Abstract

A Metacognitive Training for Schizophrenia patients (MCT) was developed to target the cognitive biases that characterize the illness. Results suggest positive MCT effects encompassing several aspects of psychopathology and subjective well-being. There are still open questions concerning the effect on different cognitive biases and the interplay between them and both psychopathology and neurocognition. Specifically, the bias against disconfirmatory evidence (BADE) has never been tested in previous trials on MCT. In this study we evaluated the feasibility of MCT combined with a cognitive remediation therapy (CACR) in schizophrenia and its effect on BADE. Moreover, we investigated the relationships between BADE and both neuropsychology and psychopathology, taking into account mutual influences on the degree of improvement. Fifty-seven schizophrenia outpatients were randomly assigned to CACR + control group or MCT+CACR and assessed at baseline and after treatment for psychopathology, neurocognition and BADE. After MCT+CACR patients showed significantly greater improvements on BADE. Although BADE baseline performances correlated with several cognitive domains, no association was found between BADE improvement and neurocognitive nor ...Continue Reading

References

Jan 1, 1992·Schizophrenia Bulletin·H D BrennerP Corrigan
Jul 1, 1991·Archives of General Psychiatry·A J SaykinP Stafiniak
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 5, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Peter F LiddleAnthony J Warren
Jul 12, 2005·The British Journal of Clinical Psychology·Steffen Moritz, Todd S Woodward
Aug 25, 2005·Journal of Abnormal Psychology·Philippa A GaretyRobert Dudley
Apr 21, 2006·Journal of Clinical and Experimental Neuropsychology·Todd S WoodwardJennifer C Whitman
Apr 25, 2006·Psychiatry Research·Steffen Moritz, Todd S Woodward
Oct 9, 2007·Current Opinion in Psychiatry·Steffen Moritz, Todd S Woodward
Apr 1, 2008·Schizophrenia Bulletin·David L PennDavid L Roberts
May 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Simona AnselmettiRoberto Cavallaro
Jun 13, 2009·Schizophrenia Bulletin·Kerry RossPhilippa Garety
Aug 12, 2009·Behaviour Research and Therapy·R ShafranG T Wilson
Sep 11, 2009·Psychiatry Research·Roberto CavallaroEnrico Smeraldi
Feb 11, 2010·Cognitive Neuropsychiatry·Steffen MoritzTania M Lincoln
Feb 20, 2010·Journal of Behavior Therapy and Experimental Psychiatry·Julia AghotorDaniela Roesch-Ely
Jul 3, 2010·Psychosomatic Medicine·Suzanne H SoShitij Kapur
Aug 5, 2010·Current Opinion in Psychiatry·Steffen MoritzTodd S Woodward
Oct 20, 2010·Journal of Advanced Nursing·Jérôme FavrodCharles Bonsack
Jan 29, 2011·Cognitive Neuropsychiatry·Ruth VeckenstedtSteffen Moritz
Feb 1, 2011·Behaviour Research and Therapy·S MoritzT S Woodward
Mar 17, 2011·The American Journal of Psychiatry·Til WykesPál Czobor
May 15, 2012·Psychiatry Research·Roberta RiccaboniRoberto Cavallaro
Mar 23, 2013·Clinical Schizophrenia & Related Psychoses·Devvarta KumarBangalore Gangadhar
Nov 5, 2013·Schizophrenia Research·Steffen MoritzDaniela Roesch-Ely
Nov 28, 2013·Clinical Schizophrenia & Related Psychoses·Urvakhsh Meherwan MehtaJagadisha Thirthalli
Apr 26, 2014·The Journal of Neuropsychiatry and Clinical Neurosciences·Malick BrikiDaniel Sechter
May 29, 2014·Clinical Psychology Review·Steffen MoritzTodd S Woodward
Jun 2, 2014·Psychiatry Research·Sarah EiflerMathias Zink
Jun 29, 2014·Schizophrenia Research·Malick BrikiPierre Vandel

❮ Previous
Next ❯

Citations

Apr 18, 2016·Psychiatry Research·Sarah EisenacherMathias Zink
Sep 10, 2016·Journal of Behavior Therapy and Experimental Psychiatry·Sarah Eisenacher, Mathias Zink
Oct 8, 2016·Neuropsychological Rehabilitation·Margherita BechiRoberto Cavallaro
Aug 2, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·M BuonocoreR Cavallaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here